EUVIMEDEUVIMED entdecken
Crossref

Peripheral nerve regeneration and synergistic pharmacology using Hericium erinaceus, lithium, and vitamin B12: The triple neuromodulatory axis hypothesis

Dražen Radanović, Lukas Rasulić, Andrija Savić, Slađana Matić, Dušan Micić, Predrag Petrović, Nevena Divac

Int. Journal of Clinical Pharmacology and Therapeutics · 01.08.2026 · 64 (08) · 438-447

DOI: 10.5414/cp204956 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.08.2026. Verfasst von Dražen Radanović und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hericium, Lithium, Nerve Regeneration, Peripheral Nerve Injuries. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Peripheral nerve injuries (PNI) frequently result in incomplete functional recovery, creating a significant translational gap despite advances in surgical techniques. While Hericium erinaceus (H. erinaceus), lithium, and vitamin B12 have individually demonstrated promising neuromodulatory and neurotrophic properties - targeting axonal growth, myelination, and neuroprotection - no existing experimental model has investigated their combined synergistic potential. This lack of integrated approach represents a major barrier to developing effective multimodal therapies. HYPOTHESIS: We propose a "triple neuromodulatory axis" hypothesis: that the combined administration of H. erinaceus, lithium, and vitamin B12 will exert a synergistic effect on peripheral nerve regeneration. This synergy is mechanistically driven by the agents' convergence on three vital pathways: neurotrophic signaling (TrkA/ERK), glial modulation (GSK-3β/β-catenin), and metabolic/methylation support. The coordinated action of this axis is hypothesized to ensure simultaneous initiation of axonal growth, rapid Schwann cell proliferation, and sustained myelination. Translational rationale: The convergence of these mechanisms suggests that the triple axis, when tested in appropriate in vivo models of nerve injury, will yield superior functional outcomes (e.g., Sciatic Functional Index) and histological repair (e.g., myelin density and axon count) compared to standard treatments or mono-treatments. CONCLUSION: The triple neuromodulatory axis provides a testable translational framework for designing future multi-arm studies aimed at validating a novel, synergistic pharmacological strategy for enhancing neurorepair in diabetic and post-traumatic neuropathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HericiumLithiumNerve RegenerationPeripheral Nerve InjuriesVitamin B 12AnimalsHumansDrug SynergismSignal Transduction

Substanzen

LithiumVitamin B 12

Zitieren

APA

Radanović, D., Rasulić, L., Savić, A., Matić, S., Micić, D., Petrović, P., & Divac, N. (2026). Peripheral nerve regeneration and synergistic pharmacology using Hericium erinaceus, lithium, and vitamin B12: The triple neuromodulatory axis hypothesis. Int. Journal of Clinical Pharmacology and Therapeutics, 64(08), 438-447. https://doi.org/10.5414/cp204956

Vancouver

Radanović D, Rasulić L, Savić A, Matić S, Micić D, Petrović P, et al. Peripheral nerve regeneration and synergistic pharmacology using Hericium erinaceus, lithium, and vitamin B12: The triple neuromodulatory axis hypothesis. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(08):438-447. doi:10.5414/cp204956

BibTeX
@article{Radanovi2026,
  author = {Radanović, Dražen and Rasulić, Lukas and Savić, Andrija and Matić, Slađana and Micić, Dušan and Petrović, Predrag and Divac, Nevena},
  title = {Peripheral nerve regeneration and synergistic pharmacology using Hericium erinaceus, lithium, and vitamin B12: The triple neuromodulatory axis hypothesis},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  year = {2026},
  volume = {64},
  number = {08},
  pages = {438--447},
  doi = {10.5414/cp204956}
}
Kostenlos starten →